WillowV1, Main, Corpus, bibRecord, 002091

The cost-effectiveness of substance abuse treatment.

Identifieur interne : 002091 ( Main/Corpus ); précédent : 002090; suivant : 002092

The cost-effectiveness of substance abuse treatment.

Auteurs : P G Barnett

Source :

Current psychiatry reports [ 1523-3812 ] ; 1999.

RBID : pubmed:11122920

English descriptors

KwdEn :
- Cost-Benefit Analysis (MeSH), Health Care Costs (MeSH), Humans (MeSH), Methadone (economics), Methadone (therapeutic use), Narcotics (economics), Narcotics (therapeutic use), Quality-Adjusted Life Years (MeSH), Smoking Cessation (economics), Substance-Related Disorders (economics), Substance-Related Disorders (therapy).
MESH :
- chemical , economics : Methadone, Narcotics.
- chemical , therapeutic use : Methadone, Narcotics.
- economics : Smoking Cessation, Substance-Related Disorders.
- therapy : Substance-Related Disorders.
- Cost-Benefit Analysis, Health Care Costs, Humans, Quality-Adjusted Life Years.

Abstract

Researchers have estimated the cost of treating substance abuse and its effects on medical care and social service expenses, but have rarely used the methods developed to evaluate medical care interventions. When outcomes are expressed as quality-adjusted life years, substance abuse treatment may be compared with other types of health care. This method has found smoking cessation and methadone maintenance to be highly cost-effective health care programs.

DOI: 10.1007/s11920-999-0027-8
PubMed: 11122920

Links to Exploration step

pubmed:11122920

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The cost-effectiveness of substance abuse treatment.</title>
<author><name sortKey="Barnett, P G" sort="Barnett, P G" uniqKey="Barnett P" first="P G" last="Barnett">P G Barnett</name>
<affiliation><nlm:affiliation>Health Economics Resource Center and Center for Health Care Evaluation, VA Palo Alto Health Care System, 795 Willow Road (152 MPD), Menlo Park, CA 94025, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:11122920</idno>
<idno type="pmid">11122920</idno>
<idno type="doi">10.1007/s11920-999-0027-8</idno>
<idno type="wicri:Area/Main/Corpus">002091</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">002091</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The cost-effectiveness of substance abuse treatment.</title>
<author><name sortKey="Barnett, P G" sort="Barnett, P G" uniqKey="Barnett P" first="P G" last="Barnett">P G Barnett</name>
<affiliation><nlm:affiliation>Health Economics Resource Center and Center for Health Care Evaluation, VA Palo Alto Health Care System, 795 Willow Road (152 MPD), Menlo Park, CA 94025, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Current psychiatry reports</title>
<idno type="ISSN">1523-3812</idno>
<imprint><date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cost-Benefit Analysis (MeSH)</term>
<term>Health Care Costs (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Methadone (economics)</term>
<term>Methadone (therapeutic use)</term>
<term>Narcotics (economics)</term>
<term>Narcotics (therapeutic use)</term>
<term>Quality-Adjusted Life Years (MeSH)</term>
<term>Smoking Cessation (economics)</term>
<term>Substance-Related Disorders (economics)</term>
<term>Substance-Related Disorders (therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Methadone</term>
<term>Narcotics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Methadone</term>
<term>Narcotics</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Smoking Cessation</term>
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cost-Benefit Analysis</term>
<term>Health Care Costs</term>
<term>Humans</term>
<term>Quality-Adjusted Life Years</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Researchers have estimated the cost of treating substance abuse and its effects on medical care and social service expenses, but have rarely used the methods developed to evaluate medical care interventions. When outcomes are expressed as quality-adjusted life years, substance abuse treatment may be compared with other types of health care. This method has found smoking cessation and methadone maintenance to be highly cost-effective health care programs.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11122920</PMID>
<DateCompleted><Year>2001</Year>
<Month>06</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>04</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1523-3812</ISSN>
<JournalIssue CitedMedium="Print"><Volume>1</Volume>
<Issue>2</Issue>
<PubDate><Year>1999</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Current psychiatry reports</Title>
<ISOAbbreviation>Curr Psychiatry Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>The cost-effectiveness of substance abuse treatment.</ArticleTitle>
<Pagination><MedlinePgn>166-71</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Researchers have estimated the cost of treating substance abuse and its effects on medical care and social service expenses, but have rarely used the methods developed to evaluate medical care interventions. When outcomes are expressed as quality-adjusted life years, substance abuse treatment may be compared with other types of health care. This method has found smoking cessation and methadone maintenance to be highly cost-effective health care programs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnett</LastName>
<ForeName>P G</ForeName>
<Initials>PG</Initials>
<AffiliationInfo><Affiliation>Health Economics Resource Center and Center for Health Care Evaluation, VA Palo Alto Health Care System, 795 Willow Road (152 MPD), Menlo Park, CA 94025, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Curr Psychiatry Rep</MedlineTA>
<NlmUniqueID>100888960</NlmUniqueID>
<ISSNLinking>1523-3812</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009294">Narcotics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>UC6VBE7V1Z</RegistryNumber>
<NameOfSubstance UI="D008691">Methadone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017048" MajorTopicYN="Y">Health Care Costs</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008691" MajorTopicYN="N">Methadone</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009294" MajorTopicYN="N">Narcotics</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016540" MajorTopicYN="N">Smoking Cessation</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>44</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year>
<Month>12</Month>
<Day>21</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2001</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2000</Year>
<Month>12</Month>
<Day>21</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11122920</ArticleId>
<ArticleId IdType="doi">10.1007/s11920-999-0027-8</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Subst Abuse Treat. 1993 May-Jun;10(3):243-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8391086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Addiction. 1999 Apr;94(4):479-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10605844</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1986 Sep 19;256(11):1456-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3747063</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1989 Feb 9;320(6):358-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2913493</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hosp Community Psychiatry. 1991 Jun;42(6):609-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1864571</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Health Soc Policy. 1993;4(3):79-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10125467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Empl Benefits J. 1991 Sep;16(3):26-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10170845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Acquir Immune Defic Syndr (1988). 1993 Jul;6(7):831-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8509983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nerv Ment Dis. 1993 Apr;181(4):227-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8473874</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1997 Dec 3;278(21):1759-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9388153</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Technol Assess Health Care. 1989;5(4):559-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2634630</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Econ. 1997 Mar-Apr;6(2):161-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9158968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Med. 1997 Mar-Apr;26(2):264-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9085397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Acquir Immune Defic Syndr (1988). 1994 May;7(5):469-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8158541</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Drug Alcohol Abuse. 1976;3(1):95-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">820188</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1991 Sep 12;325(11):775-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1870651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Stud Alcohol. 1991 Nov;52(6):517-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1661799</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Aff (Millwood). 1995 Fall;14(3):173-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7498890</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Public Health Rep. 1991 May-Jun;106(3):280-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1905049</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacoeconomics. 1997 Jun;11(6):538-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10168094</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Addict Behav. 1985;10(3):235-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3936343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1993 Apr 21;269(15):1953-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8385230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1996 Jan 11;334(2):131-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8531959</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Public Health. 1996 Jul;86(7):973-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8669521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Control Clin Trials. 1995 Feb;16(1):17-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7743786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1974 Mar 28;290(13):751</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4813755</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hosp Community Psychiatry. 1993 Dec;44(12):1166-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8132189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Milbank Q. 1995;73(1):19-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7898406</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eval Rev. 1996 Apr;20(2):160-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10182202</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Subst Abuse Treat. 1998 May-Jun;15(3):201-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9633032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Drug Alcohol Abuse. 1995 Feb;21(1):93-110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7762547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Nerv Ment Dis. 1994 Mar;182(3):157-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8113776</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Alcohol Clin Exp Res. 1981 Fall;5(4):559-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7030113</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Care. 1996 Sep;34(9):890-910</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8792779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Public Health. 1972 Oct;62(10):1397-406</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5076154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Subst Abuse Treat. 1997 Sep-Oct;14(5):445-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9437614</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002091 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002091 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    WillowV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:11122920
   |texte=   The cost-effectiveness of substance abuse treatment.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:11122920" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a WillowV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Nov 17 16:35:40 2020. Site generation: Tue Nov 17 16:39:32 2020

	Serveur d'exploration sur le saule
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le saule

The cost-effectiveness of substance abuse treatment.

The cost-effectiveness of substance abuse treatment.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki